TrialJournal of clinical pharmacology2017

Population-Based Pharmacokinetic and Exposure-Efficacy Analyses of Peginterferon Beta-1a in Patients With Relapsing Multiple Sclerosis.

Xiao Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.